Bibliometric and Visualization Analysis of Stem Cell Therapy for Erectile Dysfunction
Taotao Sun,Yipiao Liu,Penghui Yuan,Zhankui Jia,Jinjian Yang
DOI: https://doi.org/10.2147/dddt.s448483
IF: 4.3188
2024-03-09
Drug Design Development and Therapy
Abstract:Taotao Sun, 1 Yipiao Liu, 2 Penghui Yuan, 1 Zhankui Jia, 1 Jinjian Yang 1 1 Department of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China; 2 Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China Correspondence: Taotao Sun; Jinjian Yang, Department of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China, Email ; Purpose: As a common male disease, erectile dysfunction (ED) seriously affects the physical and mental health of patients. In recent years, studies have continued to point out the great potential of stem cell therapy (SCT) in the treatment of ED. The purpose of this study is to comprehensively analyze the research of SCT for ED and understand the development trends and research frontiers in this field. Methods: Publications regarding SCT and ED were retrieved and collected from the Web of Science Core Collection. CiteSpace and VOSviewer software were then utilized for bibliometric and visualization analysis. Results: A total of 524 publications were eventually included in this study. The annual number of publications in this field was increasing year by year. China and the USA were the two most productive countries. Lin GT, Lue TF and Lin CS, and the University of California San Francisco where they worked were the most productive research group and institution, respectively. The journal with the largest number of publications was The Journal of Sexual Medicine, and the following were mostly professional journals of urology and andrology. Diabetes mellitus-induced ED and cavernous nerve injury-related ED were the two most commonly constructed models of ED in studies. Concerning the types of stem cells, mesenchymal stem cells derived from adipose and bone marrow were most frequently used. Moreover, future research would mainly focus on exosomes, tissue engineering technology, extracorporeal shockwave therapy, and clinical translation. Conclusion: The research of SCT for ED will receive increasing global attention in the future. Our study provided bibliometric and visualization analysis of published literature, helping researchers understand the global landscape and frontiers in this field. More preclinical and clinical studies should be conducted to more deeply explore the underlying mechanisms of treatment and promote clinical translation. Keywords: erectile dysfunction, stem cells, bibliometric analysis, visualization, VOSviewer, citespace Erectile dysfunction (ED) is considered a condition wherein the penis is insufficiently rigid to achieve satisfactory sexual intercourse. Its prevalence among middle-aged and elderly men over 40 years old is as high as 52% and increases with age. 1,2 The number of patients suffering from ED is estimated to reach 322 million in 2025. 3 Moreover, its impact on male patients is multifaceted. On the one hand, it affects the quality of sexual life and damages the relationship between couples. 4 On the other hand, the penis is the continuation of the blood vessels of the whole body, and ED could serve as a predictor of cardiovascular diseases. 5 Timely and effective diagnosis and treatment of ED could assist in enhancing the quality of life in patients and promote physical and mental health. According to the cause, ED could be divided into three categories, namely the psychogenic, organic, and mixed types. 6 Common clinical risk factors include diabetes mellitus (DM), smoking, high blood pressure, radical pelvic surgery, stroke, drugs, aging, and other causes, all of which could promote the occurrence of ED. 4,7 Phosphodiesterase type 5 inhibitor (PDE5i) is the most important drug in the current treatment of ED, 8 with an effectiveness as high as 83%. However, patients with certain ED subtypes respond poorly to PDE5i, with response rates of 63% in DM-induced ED (DMED) and 48% in cavernous nerve injury (CNI)-related ED (CNI-ED). 9 Second and third-line treatments encompass vacuum erection devices, intraurethral suppositories, intracavernous injections, and penile implants. 4 However, limitations associated with these strategies, such as the inability to correct the pathological state of the penis and their restricted application due to side effects, cost, and unsatisfactory results, 10 which highlight the urgent need for a comprehensive exploration of the pathological mechanism and treatment strategies for ED. As is well documented, stem cells have the capability of self-renewal and can di -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal